[HTML][HTML] Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations …

B Fischer, T Robinson, C Bullen, V Curran… - International Journal of …, 2022 - Elsevier
Background Cannabis use is common, especially among young people, and is associated
with risks for various health harms. Some jurisdictions have recently moved to …

Lower-risk cannabis use guidelines: a comprehensive update of evidence and recommendations

B Fischer, C Russell, P Sabioni… - … journal of public …, 2017 - ajph.aphapublications.org
Background. Cannabis use is common in North America, especially among young people,
and is associated with a risk of various acute and chronic adverse health outcomes …

[HTML][HTML] Determining the magnitude and duration of acute Δ9-tetrahydrocannabinol (Δ9-THC)-induced driving and cognitive impairment: A systematic and meta …

D McCartney, TR Arkell, C Irwin, IS McGregor - … & Biobehavioral Reviews, 2021 - Elsevier
The increasing legal availability of cannabis has important implications for road safety. This
systematic review characterised the acute effects of Δ 9-THC on driving performance and …

Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function

CJA Morgan, TP Freeman, C Hindocha… - Translational …, 2018 - nature.com
The main active ingredient in cannabis, delta-9-tetrahydrocannabinol (THC), can acutely
induce psychotic symptoms and impair episodic and working memory. Another major …

Cannabis use and the development of tolerance: a systematic review of human evidence

M Colizzi, S Bhattacharyya - Neuroscience & Biobehavioral Reviews, 2018 - Elsevier
Previous studies have reported conflicting results in terms of acute effects of cannabis in
man. Independently of other factors, such discrepancy may be attributable to the different …

[HTML][HTML] A naturalistic examination of the perceived effects of cannabis on negative affect

C Cuttler, A Spradlin, RJ McLaughlin - Journal of affective disorders, 2018 - Elsevier
Background Cannabis is commonly used to alleviate symptoms of negative affect. However,
a paucity of research has examined the acute effects of cannabis on negative affect in …

Cognitive outcomes associated with long-term, regular, recreational cannabis use in adults: A meta-analysis.

ME Lovell, J Akhurst, C Padgett, MI Garry… - Experimental and …, 2020 - psycnet.apa.org
Despite research advances, it remains unclear if long-term, regular cannabis use harms
cognition once intoxication has passed. Our meta-analysis aimed to investigate the …

Dark Classics in Chemical Neuroscience: Δ9-Tetrahydrocannabinol

SD Banister, JC Arnold, M Connor… - ACS chemical …, 2019 - ACS Publications
Cannabis (Cannabis sativa) is the most widely used illicit drug in the world, with an
estimated 192 million users globally. The main psychoactive component of cannabis is (−) …

Daily patterns of marijuana and alcohol co‐use among individuals with alcohol and cannabis use disorders

J Metrik, RL Gunn, KM Jackson… - Alcoholism: Clinical …, 2018 - Wiley Online Library
Background The study aims were to examine daily associations between marijuana and
alcohol use and the extent to which the association differs as a function of cannabis use …

The impact of THC and CBD in schizophrenia: a systematic review

S Ahmed, RM Roth, CN Stanciu, MF Brunette - Frontiers in Psychiatry, 2021 - frontiersin.org
Background: People with schizophrenia are more likely to develop cannabis use disorder
(CUD) and experience worse outcomes with use. Yet as cannabis is legalized for medical …